Cardiovascular

Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in Oman.

Cardiovascular Diseases

Learn about the latest trends, discover events and innovations in the changing world of cardiovascular disease.

Science in Cardiovascular Diseases

Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you

ODYSSEY Outcomes

Odyssey Outcomes - Mortality

NEJM Odyssey Outcomes

Odyssey Outcomes - PVD Results

Odyssey Outcomes - CABG Results

PCSK9 inhibitors and ACS

Changing trends in VTE: Pulmonary Embolism Cases on Rise within the Last Decade

Utility of Pregnancy-Adapted YEARS Algorithm in Diagnosis of Pulmonary Embolism

VTE Comparison of Pregnancy-Specific Risk Scoring Systems in Hospitalized Maternity Patients

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

ESC/EAS 2019 International Guidelines

Odyssey Outcomes - Total Events Results

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources

PCSK9 inhibitors and ACS

Utility of Pregnancy-Adapted YEARS Algorithm in Diagnosis of Pulmonary Embolism

VTE Comparison of Pregnancy-Specific Risk Scoring Systems in Hospitalized Maternity Patients

VTE prophylaxis in medically ill patients

Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress

Clinical practice experience in patients with familial hypercholesterolemia (FH) from the SAFEHEART registry

VTE prophylaxis in medically ill patients

Evaluation of comparative efficacy and safety of thromboprophylaxis agents among critically ill patients

Evaluation of lipid management following ACS

Prognostic impact of achieving LDL cholesterol guidelines

The European experience: SWEDEHEART and AIFA registries

Understanding de-escalation in antiplatelet therapy

Events

Stay up to date and register for the latest events and view webinar recordings.

Dyslipidemia Webinars: Optimizing Dyslipidemia management

VTE prevention for acutely ill patients

Dyslipidemia Webisodes: Mortality data with Prof. Tunon

Dyslipidemia Expert Exchange: Best practice approaches in dyslipidemia management

VTE Safety Zone: Assessing the VTE Risk in Hospital and Beyond

VTE Safety Zone: The Role of Thromboprophylaxis for the Prevention of VTE

VTE Safety Zone: VTE in general surgery from risk assessment to appropriate thromboprophylaxis

VTE Safety Zone: Prevention of VTE in Medically ill Patients COVID-19 and BEYOND

VTE Safety Zone: Primary VTE Prophylaxis in Patients with Cancer Undergoing Major Abdominal/Pelvic Surgery

YOU WILL NOW BE LEAVING THE SITE

By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

Continue

This website is intended exclusively for healthcare professionals residing and/or working in Oman.

Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.